MAGELLAN HEALTH, INC. MGLN Balance Sheet

Magellan health, inc. (MGLN)

Balance Sheet / Yearly

Mar'20	Dec'19	Sep'19	Jun'19	Mar'19	Dec'18	Sep'18	Jun'18	Mar'18	Dec'17	Sep'17	Jun'17	Mar'17	Dec'16	Sep'16	Jun'16	Mar'16	Dec'15	Sep'15	Jun'15	Mar'15	Dec'14	Sep'14	Jun'14	Mar'14	Dec'13	Sep'13	Jun'13	Mar'13	Dec'12	Sep'12	Jun'12	Mar'12	Dec'11	Sep'11	Jun'11	Mar'11	Dec'10	Sep'10	Jun'10	Dec'09
Assets [Abstract]
Current Assets:
Cash and cash equivalents ($146,455 and $123,877 restricted at December 31, 2019 and March 31, 2020, respectively)
383	325	376	260	233	272	234	246	394	398	504	281	273	304	164	198	86	249	96	167	231	255	368	185	261	203	281	179	188	189	209	168	171	119	142	81	154	337	284	230	196
Restricted cash
-	-	-	-	-	-	-	-	-	-	-	-	-	-	55	80	80	-	135	131	205	215	165	167	264	236	208	189	221	226	245	208	184	185	155	103	101	116	97	123	159
Accounts receivable, net
923	890	812	810	779	756	820	839	748	660	622	628	634	606	497	506	446	428	417	407	354	353	302	301	202	238	157	165	146	138	121	120	133	121	114	183	112	106	99	116	114
Short-term investments ($318,464 and $329,237 restricted at December 31, 2019 and March 31, 2020, respectively)
350	334	336	371	412	382	374	412	329	310	312	300	306	297	308	284	329	322	361	312	261	224	150	147	181	175	212	228	224	201	155	180	161	192	240	325	339	189	214	195	162
Deferred income taxes
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	24	26	26	-	36	36	37	37	29	31	31	31	33	34	34	35	33	24	30	28	43	57	57
Pharmaceutical inventory
42	44	48	45	47	40	44	50	37	40	48	59	62	58	61	62	55	50	44	42	34	39	40	44	47	49	47	49	47	45	41	38	43	39	-	-	-	27	-	-	-
Other current assets ($38,602 and $42,900 restricted at December 31, 2019 and March 31, 2020, respectively)
106	78	87	96	99	95	102	119	108	72	52	73	52	51	69	75	67	46	99	81	77	52	67	72	62	48	48	46	40	38	43	42	32	37	72	92	80	51	66	57	62
Total Current Assets
1,807	1,673	1,660	1,584	1,573	1,547	1,576	1,668	1,618	1,483	1,541	1,343	1,329	1,319	1,156	1,209	1,066	1,097	1,179	1,169	1,191	1,140	1,130	956	1,057	989	985	891	901	871	850	793	762	732	759	809	818	858	805	780	753
Property and equipment, net
143	138	141	145	149	150	154	160	159	158	161	165	166	172	169	173	174	174	177	177	176	171	175	172	167	172	163	163	162	136	133	129	120	118	114	115	110	111	108	109	108
Long-term investments ($10,111 and $6,178 restricted at December 31, 2019 and March 31, 2020, respectively)
6	10	7	22	17	3	4	20	20	17	10	8	7	7	5	3	7	3	9	29	41	43	50	23	27	32	15	26	25	32	22	8	2	7	13	17	48	94	89	41	67
Deferred income taxes
0	1	2	3	3	3	1	1	1	0	5	4	4	3	9	25	27	26	-	-	-	3	-	-	-	-	-	-	-	-	-	-	-	-	-	1	0	0	0	2	17
Other long-term assets
96	82	129	107	90	24	51	30	21	22	40	26	15	12	61	38	20	11	12	13	13	9	11	9	9	7	15	15	9	9	9	9	10	10	10	10	5	2	2	2	2
Goodwill
1,018	1,018	1,018	1,018	1,018	1,018	1,015	1,014	1,013	1,006	745	745	742	742	716	634	634	621	623	623	574	566	566	557	488	488	426	426	426	426	426	426	426	426	426	426	426	426	426	426	426
Other intangible assets, net
153	167	181	196	218	231	245	243	256	268	156	165	177	186	149	116	128	133	141	149	131	133	140	146	68	69	28	30	32	34	37	39	42	44	47	49	52	53	56	59	64
Total Assets
3,224	3,092	3,141	3,077	3,071	2,979	3,048	3,139	3,091	2,957	2,662	2,459	2,443	2,443	2,269	2,201	2,059	2,069	2,143	2,163	2,129	2,068	2,075	1,866	1,817	1,759	1,634	1,553	1,557	1,512	1,479	1,408	1,364	1,341	1,371	1,430	1,462	1,549	1,490	1,422	1,441
Liabilities and Equity [Abstract]
Current Liabilities:
Accounts payable
104	88	92	75	75	72	73	76	73	74	66	70	82	95	79	71	82	86	100	58	53	63	65	63	35	42	15	12	17	17	14	17	17	18	19	14	24	31	22	24	27
Accrued liabilities
320	284	307	260	260	231	209	268	246	193	173	179	165	202	196	171	152	139	227	159	142	146	121	144	173	134	107	74	87	100	92	87	81	106	108	92	87	105	95	71	93
Short-term contingent consideration
-	-	0	0	-	8	7	7	6	6	8	9	9	9	0	0	90	91	-	-	-	8	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Medical claims payable
392	409	430	401	399	393	402	397	390	327	213	198	174	184	199	216	211	250	263	255	277	278	281	234	240	228	217	205	210	198	198	181	166	137	140	145	144	142	147	153	143
Other medical liabilities
128	124	144	166	183	169	162	183	207	177	193	189	202	197	170	136	138	136	147	141	97	72	54	79	65	67	74	76	80	76	83	82	97	106	95	94	97	109	87	86	104
Current debt, finance lease and deferred financing obligations
84	3	3	21	25	24	64	90	61	112	19	428	428	403	118	50	22	19	16	15	15	15	15	2	3	3	2	2	3	-	-	-	-	-	0	0	0	0	0	0	-
Total Current Liabilities
1,030	910	978	925	943	898	918	1,023	985	892	675	1,076	1,063	1,092	765	647	697	724	755	629	587	585	537	525	517	476	417	371	399	393	389	369	362	369	365	347	353	390	352	337	369
Long-term debt, finance lease and deferred financing obligations
647	679	695	712	722	728	733	734	736	740	745	201	207	214	419	426	231	238	246	249	252	254	258	21	22	23	24	24	25	-	-	-	-	-	-	-	-	-	0	0	-
Deferred income taxes
23	17	15	11	11	11	12	10	11	12	-	-	-	-	-	-	-	-	28	27	28	7	43	40	38	42	32	34	32	34	30	24	20	18	11	-	-	-	-	-	-
Tax contingencies
16	14	16	17	16	16	14	15	14	14	14	15	14	13	12	13	13	12	8	11	11	12	14	34	33	32	32	62	61	60	61	105	104	102	109	120	118	117	120	121	118
Long-term contingent consideration
-	-	-	-	2	2	2	2	2	1	0	1	1	1	10	3	2	0	1	63	61	49	47	43	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Deferred credits and other long-term liabilities
76	73	74	76	81	36	34	35	36	19	18	17	20	15	16	21	20	20	19	19	19	19	21	21	20	17	9	7	7	6	5	4	4	4	6	5	6	2	2	2	2
Total Liabilities
1,793	1,694	1,779	1,743	1,777	1,693	1,716	1,820	1,786	1,680	1,454	1,311	1,307	1,339	1,224	1,112	966	996	1,060	1,000	959	929	923	686	632	592	516	500	526	494	486	503	491	495	492	474	479	510	475	461	490
Redeemable non-controlling interest
-	-	-	-	-	-	-	-	-	-	4	3	4	4	4	4	6	5	8	8	8	5	7	8	9	10	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
STOCKHOLDERS' EQUITY
Preferred stock, par value $.01 per share:Authorized-10,000 shares at December 31, 2019 and March 31, 2020-Issued and outstanding-none
-	-	-	-	-	-	0	0	0	-	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Common stock, par value $.01 per share: Authorized-100,000 shares at December 31, 2019 and March 31, 2020-Issued and outstanding-54,285 and 23,935 shares at December 31, 2019, respectively, and 54,631 and 24,969 shares at March 31, 2020, respectively
0	0	0	0	0	0	0	0	0	0	0	0	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Other Stockholders' Equity:
Additional paid-in capital
1,402	1,386	1,371	1,364	1,337	1,326	1,324	1,311	1,296	1,274	1,248	1,212	1,200	1,186	1,162	1,150	1,140	1,124	1,110	1,095	1,070	1,018	994	973	933	922	890	872	861	848	837	815	810	804	794	782	757	725	647	638	614
Retained earnings
1,493	1,475	1,454	1,433	1,419	1,419	1,447	1,420	1,406	1,399	1,344	1,312	1,307	1,289	1,254	1,228	1,224	1,211	1,184	1,191	1,187	1,179	1,158	1,131	1,126	1,100	1,082	1,034	1,003	975	938	871	844	824	794	763	728	694	661	616	555
Warrants outstanding
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-	0	5	5	5
Accumulated other comprehensive (loss) income
-0	0	0	0	-0	-0	-0	-0	-0	-0	-0	-0	-0	-0	-0	-0	-0	-0	-0	-0	-0	-0	-0	0	-0	-0	-0	-0	-0	-0	0	-0	0	-0	-0	0	0	0	0	-0	0
Treasury stock, at cost, 29,662 and 29,662 shares at December 31, 2019 and March 31, 2020, respectively
1,464	1,464	1,464	1,464	1,464	1,461	1,440	1,412	1,397	1,397	1,391	1,381	1,376	1,376	1,376	1,294	1,278	1,269	1,219	1,133	1,096	1,064	1,009	934	883	866	854	854	833	806	783	783	783	783	709	589	503	381	300	300	225
Total Stockholders' Equity
1,431	1,397	1,362	1,334	1,293	1,285	1,331	1,318	1,305	1,276	1,202	1,143	1,131	1,099	1,040	1,084	1,086	1,066	1,075	1,154	1,161	1,133	1,144	1,171	1,176	1,156	1,118	1,053	1,031	1,017	992	904	872	845	879	956	983	1,039	1,015	960	950
Total Liabilities and Stockholders' Equity
3,224	3,092	3,141	3,077	3,071	2,979	3,048	3,139	3,091	2,957	2,662	2,459	2,443	2,443	2,269	2,201	2,059	2,069	2,143	2,163	2,129	2,068	2,075	1,866	1,817	1,759	1,634	1,553	1,557	1,512	1,479	1,408	1,364	1,341	1,371	1,430	1,462	1,549	1,490	1,422	1,441